Vector-Based Foreign Material Introduction TRIZ Cases

Negative regulator genes are disrupted to boost rebaudioside M accumulation in Stevia, improving sweetener yield and quality.

Wild Spinacia tetrandra fragments add resistance to downy mildew, Stemphylium, and CMV while avoiding a linked lethal factor.

Engineered plasmids boost miRNA that degrades checkpoint mRNA, lowering PD-1 or PD-L1 expression to restore immune homeostasis.

Combining SlAT2 and AP2e boosts acyl sugar production in tomato trichomes, improving whitefly mortality and resistance durability.

Specific CENH3 genome mutations induce wheat haploids without transgenic plants, cutting breeding time and enabling rapid homozygosity.

Marker-assisted selection of sex-expression QTL helps breeders identify desired flower ratios early and reduce costly field phenotyping.

Plasmid-encoded miRNA degrades or inactivates cytokine mRNA to lower cytokine bioavailability and help restore homeostasis.

Low-homology synthetic snRNA promoters reduce plasmid recombination and deletions, enabling more stable multiplex CRISPR editing in plants.

Recombinant plasmids boost miRNA production to degrade target mRNA and lower complement or factor bioavailability for homeostatic regulation.

Stepwise conductivity increases in anion exchange chromatography separate empty AAV capsids and enrich full capsids for scalable, consistent production.

A complementary nucleic acid plus poly(A) region stabilizes target mRNA tails to extend translation and raise protein expression in haploinsufficiency.

Surface cysteine mutations enable thioether attachment of ligands, nanoparticles, or drugs to AAV capsids for more selective targeting.

Recombinant plasmids delivered by AAV boost miRNA production to degrade CXCR4 mRNA, helping restore homeostasis in dysregulated disease states.

Endothelial expression of CTLA4-Ig, thrombomodulin, and CD46 in alpha-Gal-deficient pigs reduces rejection and coagulation dysregulation.

Preincubating AAV with albumin helps shield vectors from neutralizing antibodies, improving transduction without immunosuppression.

Recombinant plasmids boost miRNA production to degrade serotonin receptor mRNA, lowering receptor bioavailability and restoring homeostatic balance.

Engineered plasmids raise miRNA levels to selectively degrade kinase mRNA, reducing harmful overexpression while limiting off-target suppression.

Recombinant plasmids encoding miRNA degrade cytokine mRNA to lower harmful overexpression and help restore inflammatory homeostasis.

Recombinant plasmids boost miRNA production to degrade serotonin receptor mRNA, helping restore homeostasis by lowering receptor expression.

Plasmid-delivered miRNA degrades cytokine mRNA to curb overexpression, restore homeostasis, and help prevent inflammatory disease.

Modified rab17 promoters and BBM plastid delivery improve mature tissue transformation while limiting premature transgene excision.

Laser-induced plasma bubbles deliver biomolecules into intact plant cells, avoiding sterile tissue culture and reducing somaclonal variation.

Targeting AED3-1 protease with shRNA or loss-of-function edits limits proteolysis and boosts heterologous protein accumulation in plants.

Upregulated miRNA from a recombinant plasmid degrades apolipoprotein B mRNA to lower biomolecule bioavailability and restore balance.

CRISPR editing of TFL genes reduces environmental flowering dependence in Rosaceae plants, shortening juvenile phase and improving yield.

Co-incubating developing cereal inflorescences with transgene-modified Agrobacterium avoids tissue culture and enables reproducible genotype-independent transgenic seeds.

A kanamycin-based lentiviral backbone replaces ampicillin resistance and refines LTR and promoter elements to raise titer and purity.

Plasmid-encoded miRNA creates feedback suppression of cytokine mRNA, lowering inflammatory biomolecule levels while helping restore homeostasis.

Recombinant plasmids raise miRNA levels to silence serotonin receptor mRNA, reducing receptor bioavailability and restoring homeostatic balance.

Recombinant plasmids raise miRNA levels to degrade serotonin receptor mRNA and restore expression balance linked to homeostatic disease.

Pre-culture plus osmotic shock boosts rAAV yield and purity by releasing virus into media without cell disruption or lengthy purification.

Recombinant plasmids boost miRNA expression to degrade complement and factor mRNA, lowering biomolecule bioavailability and helping restore homeostasis.

Recombinant plasmids boost miRNA production to degrade serotonin receptor mRNA, helping control receptor dysregulation and restore homeostasis.

HT gene editing reduces self-incompatibility in diploid potatoes, enabling stable inbred lines and hybrid breeding in Solanaceae.

Retaining murine CDRs in a humanized anti-CD94 antibody preserves CD94 binding and T-cell activation while lowering immunogenicity.

A recessive amf1-1 allele enables Angelonia flowers with stronger, maturing color intensity while maintaining uniform and predictable breeding performance.

AAV-delivered plasmids boost miRNA production to degrade CXCR4 mRNA, reducing dysregulated CXCR4 expression and restoring homeostasis.

Endornaviral RDRP amplifies recombinant satellite RNA to enable heritable plant trait changes with stronger stress, pest, and pathogen resistance.

Cloned R genes such as c630 and c516 shorten breeding time while giving solanaceous plants broad resistance to PVY and PVA strains.

Shorter female corn rows improve pollen distribution to interior plants, raising hybrid seed yield, standability, and land-use efficiency.

Recombinant plasmids increase miRNA that degrades serotonin receptor mRNA, reducing receptor bioavailability to restore homeostatic balance.

Plasmid-delivered miRNA boosts intracellular RNA interference to degrade target cytokine mRNA and restore biomolecule homeostasis.

Recombinant plasmids boost miRNA production to degrade serotonin receptor mRNA, lowering receptor bioavailability and helping restore homeostasis.

Target cells upregulate plasmid-encoded miRNA that degrades cytokine mRNA, lowering inflammatory biomolecule bioavailability.

Recombinant plasmids increase miRNA production to silence serotonin receptor mRNA and restore homeostatic balance with targeted regulation.

Targeted miRNA plasmids silence checkpoint mRNA such as PD-1 and PD-L1 to curb harmful overexpression while limiting off-target immune effects.

Plasmid-delivered miRNA degrades cytokine mRNA to curb harmful overexpression and restore inflammatory homeostasis.

Synthetic miRNA plasmids use cellular processing to degrade immune checkpoint mRNA and lower PD-1, PD-L1, CTLA4, or IDO1 bioavailability.

CRISPR/Cas9 knockout of the TaMLR1 susceptibility gene boosts wheat resistance to stripe rust, powdery mildew, and Gibberella zeae.

Recombinant plasmids raise miRNA levels that target serotonin receptor mRNA, reducing receptor bioavailability to help restore homeostasis.

Recombinant plasmids induce miRNA that degrades target mRNA, lowering complement and factor bioavailability to treat dysregulation.

Encoded miRNA targets cytokine mRNA for degradation, lowering cytokine bioavailability and helping restore inflammatory homeostasis.

Recombinant plasmids raise miRNA levels to degrade complement or factor mRNA, improving regulation where existing therapies fall short.

MiMe replaces meiotic recombination and chromosome reduction with clonal gamete formation to produce uniform polyploid potato seeds.

This case examines modified plant cells using TPS, TPP, and P450 pathways to improve herbicide resistance and stress tolerance.

Cation exchange chromatography removes empty AAV capsids to eliminate hepatotoxicity and immune responses in gene therapy products.

Hybrid maize variety X13B656 uses locus conversion to introduce specific resistance traits into proprietary inbred lines.